Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- carboplatin
- torsemide
Interactions between your drugs
CARBOplatin torsemide
Applies to: carboplatin, torsemide
MONITOR: The concomitant use of loop diuretics with carboplatin may increase the risk of ototoxicity. Loop diuretics, especially ethacrynic acid and high doses of furosemide, and platinum compounds have been individually associated with ototoxicity. Carboplatin is generally considered to be less neurotoxic and ototoxic than cisplatin; however, hearing loss has been reported when pediatric patients received high doses of carboplatin with other ototoxic agents.
MANAGEMENT: It is recommended to regularly monitor auditory function if concomitant use is necessary. Patients should be advised to promptly notify their physician if they experience hearing loss or tinnitus.
References (7)
- (2001) "Product Information. Edecrin (ethacrynic acid)." Merck & Co., Inc
- (2001) "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
- Brock PR, Knight KR, Freyer DR, et al. (2012) "Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale." J Clin Oncol, 30, p. 2408-17
- Parsons SK, Neault MW, Lehmann, et al. (1998) "Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma." Bone Marrow Transplant, 22, p. 669-74
- Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) "Understanding platinum-induced ototoxicity." Trends Pharmacol Sci, 34, p. 458-69
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Lynparza
Lynparza (olaparib) is used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Gemzar
Gemzar is used to treat cancers of the pancreas, lung, breasts and ovaries. Learn about side ...
Doxil
Doxil is used for kaposi's sarcoma, multiple myeloma, ovarian cancer
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.